Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ludwig L. Albornoz"'
Autor:
Vanessa Bedoya-Joaqui, María I. Gutiérrez-López, Paola A. Caicedo, María F. Villegas-Torres, Ludwig L. Albornoz-Tovar, Juan D. Vélez, Alejandra Hidalgo-Cardona, Gabriel J. Tobón, Carlos A. Cañas
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-6 (2023)
Abstract Background Viruses are constantly changing as a result of mutations, and new viral variants are expected to appear over time. The virus that causes coronavirus disease 2019, severe acute respiratory syndrome coronavirus 2, is not excluded fr
Externí odkaz:
https://doaj.org/article/ad05440c727a428f81ba06a6545e65b2
Autor:
Nardhy Gomez-Lopez, Roberto Romero, María Fernanda Escobar, Javier Andres Carvajal, Maria Paula Echavarria, Ludwig L. Albornoz, Daniela Nasner, Derek Miller, Dahiana M. Gallo, Jose Galaz, Marcia Arenas-Hernandez, Gaurav Bhatti, Bogdan Done, Maria Andrea Zambrano, Isabella Ramos, Paula Andrea Fernandez, Leandro Posada, Tinnakorn Chaiworapongsa, Eunjung Jung, Valeria Garcia-Flores, Manaphat Suksai, Francesca Gotsch, Mariachiara Bosco, Nandor Gabor Than, Adi L. Tarca
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-19 (2023)
Gomez-Lopez et al. profile the plasma proteome of pregnant and non-pregnant COVID-19 patients and controls. Shared and pregnancy-specific proteomic changes are identified in COVID-19 patients compared to controls, with the proteome accurately identif
Externí odkaz:
https://doaj.org/article/0c97c424ec824888a03409f7da709499
Autor:
Natasha D Durham, Aditi Agrawal, Eric Waltari, Derek Croote, Fabio Zanini, Mallorie Fouch, Edgar Davidson, Olivia Smith, Esteban Carabajal, John E Pak, Benjamin J Doranz, Makeda Robinson, Ana M Sanz, Ludwig L Albornoz, Fernando Rosso, Shirit Einav, Stephen R Quake, Krista M McCutcheon, Leslie Goo
Publikováno v:
eLife, Vol 8 (2019)
Eliciting broadly neutralizing antibodies (bNAbs) against the four dengue virus serotypes (DENV1-4) that are spreading into new territories is an important goal of vaccine design. To define bNAb targets, we characterized 28 antibodies belonging to ex
Externí odkaz:
https://doaj.org/article/ccae0927312e48c899d2a400f15ffaf6
Autor:
Gustavo A, Ospina-Tascón, Luis Eduardo, Calderón-Tapia, Alberto F, García, Virginia, Zarama, Freddy, Gómez-Álvarez, Tatiana, Álvarez-Saa, Stephania, Pardo-Otálvaro, Diego F, Bautista-Rincón, Mónica P, Vargas, José L, Aldana-Díaz, Ángela, Marulanda, Alejandro, Gutiérrez, Janer, Varón, Mónica, Gómez, María E, Ochoa, Elena, Escobar, Mauricio, Umaña, Julio, Díez, Gabriel J, Tobón, Ludwig L, Albornoz, Carlos Augusto, Celemín Flórez, Guillermo Ortiz, Ruiz, Eder Leonardo, Cáceres, Luis Felipe, Reyes, Lucas Petri, Damiani, Alexandre B, Cavalcanti, Nicol, Guarín
Publikováno v:
JAMA. 326(21)
The effect of high-flow oxygen therapy vs conventional oxygen therapy has not been established in the setting of severe COVID-19.To determine the effect of high-flow oxygen therapy through a nasal cannula compared with conventional oxygen therapy on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86db102bd425f5ce42e40f6098b7995e
https://pubmed.ncbi.nlm.nih.gov/35377724
https://pubmed.ncbi.nlm.nih.gov/35377724
Autor:
Neal Alexander, María del Mar Castro, Isabella Caicedo, Adriana Medina, Ludwig L. Albornoz, Maria Adelaida Gomez, Helen Johanna Ortiz-Rojas, Carmen Manuela Castillo
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0256566 (2021)
PLoS ONE
PLoS ONE
BackgroundAdequate testing is critically important for control of the SARS-CoV-2 pandemic. Antibody testing is an option for case management and epidemiologic studies, with high specificity and variable sensitivity. However, characteristics of local
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f725cc4f3504e8612950a1264fbabaa5
Autor:
Jubby Marcela Gálvez, Henry Mauricio Chaparro-Solano, Ángela María Pinzón-Rondón, Ludwig L. Albornoz, Juan Mauricio Pardo-Oviedo, Fabio Andrés Zapata-Gómez, Andrés Felipe Patiño-Aldana, Andrea del Pila Hernández-Rodríguez, Mateo Díaz-Quiroz, Ángela María Ruiz-Sternberg
Publikováno v:
Infection, Genetics and Evolution
The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is the etiopathogenic agent of COVID-19, a condition that has led to a formally recognized pandemic by March 2020 (World Health Organization -WHO). The SARS-CoV-2 genome is constit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2b9b3bd894c0ea724b21791c35c0f6d
https://doi.org/10.1016/j.meegid.2021.105192
https://doi.org/10.1016/j.meegid.2021.105192
Autor:
Ana Sanz, Fabio Zanini, Aditi Agrawal, Mccutcheon Krista, Stephen R. Quake, Shirit Einav, Derek Croote, Olivia Smith, Fernando Rosso, John E. Pak, Leslie Goo, Benjamin J. Doranz, Makeda Robinson, Edgar Davidson, Esteban Carabajal, Ludwig L Albornoz, Eric Waltari, Mallorie E. Fouch, Natasha D. Durham
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d14542558015096336b25971012c2c2d
https://doi.org/10.7554/elife.52384.sa2
https://doi.org/10.7554/elife.52384.sa2
Autor:
Olivia Smith, John E. Pak, Ana Sanz, Leslie Goo, Natasha D. Durham, Esteban Carabajal, Fabio Zanini, Makeda Robinson, Fernando Rosso, Ludwig L Albornoz, Edgar Davidson, Shirit Einav, Mallorie E. Fouch, Eric Waltari, Krista M. McCutcheon, Benjamin J. Doranz, Stephen R. Quake, Derek Croote, Aditi Agrawal
Publikováno v:
eLife, Vol 8 (2019)
eLife
eLife
Eliciting broadly neutralizing antibodies (bNAbs) against the four dengue virus serotypes (DENV1-4) that are spreading into new territories is an important goal of vaccine design. To define bNAb targets, we characterized 28 antibodies belonging to ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1878176fc9ba5c858b7a69a42862e8cb
https://elifesciences.org/articles/52384
https://elifesciences.org/articles/52384
Autor:
Fernando Rosso, Fabio Zanini, Natasha D. Durham, Makeda Robinson, Shirit Einav, Ana Sanz, Ludwig L Albornoz, Eric Waltari, Aditi Agrawal, Derek Croote, Benjamin J. Doranz, Krista M. McCutcheon, Mallorie E. Fouch, Leslie Goo, Olivia Smith, John E. Pak, Esteban Carabajal, Stephen R. Quake, Edgar Davidson
Eliciting broadly neutralizing antibodies (bNAbs) against the four dengue virus serotypes (DENV1-4) that are spreading into new territories is an important goal of vaccine design. To delineate bNAb targets, we characterized 28 monoclonal antibodies b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::956f05bf7b551b61a38ae6d481a04b4d
Autor:
Malaya K. Sahoo, Ana Sanz, Leslie Goo, Fabio Zanini, Jose G. Montoya, Ludwig L Albornoz, Shirit Einav, Eliana Ortiz-Lasso, Fernando Rosso, Derek Croote, Stephen R. Quake, Makeda Robinson, Benjamin A. Pinsky
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance A fraction of the 400 million people infected with dengue annually progresses to severe dengue (SD). Yet, there are currently no biomarkers to predict disease progression. We profiled the landscape of host transcripts and viral RNA in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16707debb76eeb5ce73a83948550f1e2
https://doi.org/10.1073/pnas.1813819115
https://doi.org/10.1073/pnas.1813819115